Tilray Overview

  • Founded
  • 2013

Founded
  • Status
  • Public

  • Employees
  • 1,700

Employees
  • Stock Symbol
  • TLRY

Stock Symbol
  • Investments
  • 14

  • Share Price
  • $3.15

  • (As of Friday Closing)

Tilray General Information

Description

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater.

Contact Information

Website
www.tilray.com
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Other Industries
Distributors/Wholesale
Stock Exchange
NAS
Primary Office
  • Post Office Box 20009
  • 269 Erie Street South
  • Leamington, Ontario N8H 3C4
  • Canada

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tilray Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.15 $3.12 $3.02 - $17.91 $1.51B 481M 26.7M $0.18

Tilray Financials Summary

In Thousands,
USD
TTM 28-Feb-2022 FY 2021 31-May-2021 FY 2020 31-May-2020 FY 2019 31-May-2019
EV 3,350,478 8,002,420 1,126,025 1,632,738
Revenue 617,283 513,085 405,326 179,303
EBITDA 229,538 (249,177) (54,145) (26,187)
Net Income 41,681 (367,421) (102,540) (25,037)
Total Assets 5,819,436 6,025,362 1,737,932 1,804,576
Total Debt 732,871 938,659 302,144 361,118
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Tilray Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Tilray‘s full profile, request access.

Request a free trial

Tilray Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquir
Pharmaceuticals
Leamington, Canada
1,700 As of 2022
00000
0.000 0000-00-00
00000000 00000

000000

niam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute i
00000 000000000000000 000 0000000000000
Toronto, Canada
000 As of 0000
00.000
0.000 0000-00-00
000000000 00.000

000000

uptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proi
0000000000000
Wakefield, MA
0000 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Tilray Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cronos Group (Pharmaceuticals) Corporation Toronto, Canada 000 00.000 000000000 00.000
00000000 Formerly PE-Backed Wakefield, MA 0000 00000 000000000 00000
000000 000000 Formerly Accelerator/Incubator backed Smiths Falls, Canada 0000 00000 000000000
0000000000 0000000 Corporation Moncton, Canada 000 00000 00000000
0000 Corporation Kanata, Canada 000 00000 000000000 00000
You’re viewing 5 of 8 competitors. Get the full list »

Tilray Executive Team (24)

Name Title Board Seat Contact Info
Michael Kruteck Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Denise Faltischek Executive & Chief Strategy Officer, Strategy
Rita Seguin Chief Human Resources Officer
Lloyd Brathwaite Chief Information Officer
Berrin Noorata Chief Corporate Affairs Officer
You’re viewing 5 of 24 executive team members. Get the full list »

Tilray Board Members (21)

Name Representing Role Since
0000000 0000000 Self Board Member & Founder 000 0000
000000000 00.00000 Tilray Board Member 000 0000
00000 000000000 Self Board Member 000 0000
00000 00000 Self Chief Executive Officer & Chairman 000 0000
0000 00000 Self Board Member 000 0000
You’re viewing 5 of 21 board members. Get the full list »

Tilray Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tilray Investments & Acquisitions (14)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 30-May-2022 0000 00000 Distributors/Wholesale
000000000000 07-Dec-2021 0000000000 00000 Beverages 00000 000
000000 000000 17-Aug-2021 0000 00000 Specialty Retail 00000 000
000000 30-Apr-2021 0000000000 00.000 Pharmaceuticals 0000000 0
Privateer Holdings 12-Dec-2019 Merger/Acquisition 00.000 Private Equity 0000 0000
You’re viewing 5 of 14 investments and acquisitions. Get the full list »

Tilray Subsidiaries (5)

Company Name Industry Location Founded
Smith & Sinclair Food Products London, United Kingdom 2014
000000000 00000000 PE/Buyout Seattle, WA 0000
000000000000 00000 Beverages Breckenridge, CO 0000
00000000 0000000 0 Food Products Winnipeg, Canada 0000
000000 00000000 00 Cultivation Leamington, Canada 0000
To view Tilray’s complete subsidiaries history, request access »